Monoclonal antibodies to human tumor necrosis factor α: In vitro and in vivo application
- 31 May 1990
- Vol. 2 (3) , 162-169
- https://doi.org/10.1016/1043-4666(90)90011-h
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- T Cell-Mediated Production of Tumour Necrosis Factor-alpha by MonocytesScandinavian Journal of Immunology, 1988
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987
- Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.The Journal of Experimental Medicine, 1987
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Production and characterization of monoclonal antibodies against recombinant human tumor necrosis factor/cachectinBiochemical and Biophysical Research Communications, 1986
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970